PRF Technologies (PRFX) vs Sonoma Pharmaceuticals (SNOA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sonoma Pharmaceuticals is the larger company by market cap ($5.6 million vs $3.0 million), about 1.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRFX | SNOA |
|---|---|---|
| Share price | $0.8587 | $1.16 |
| Market cap | $3.00M | $5.55M |
| 1-day change | -2.16% | -4.92% |
| EPS (TTM) | $-4.09 | $-1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.95 | $4.30 |
| 52-week low | $0.851 | $0.85 |
| Distance from 52-week high | -89.20% | -73.02% |
| Average volume | 294.15K | 107.65K |
| Shares outstanding | 3.50M | 4.79M |
| Employees | 6 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About PRF Technologies
PRFX stock →PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Sonoma Pharmaceuticals
SNOA stock →Sonoma Pharmaceuticals, Inc. develops and produces stabilized hypochlorous acid (HOCl) products for wound and eye care, oral and nasal care, podiatry, animal health care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
Health Care · Medical/Dental Instruments · 10 employees
PRFX vs SNOA FAQ
Which is bigger, PRF Technologies or Sonoma Pharmaceuticals?
Sonoma Pharmaceuticals (SNOA) is larger, with a market capitalization of $5.55M compared with $3.00M for PRF Technologies (PRFX).
Are PRF Technologies and Sonoma Pharmaceuticals in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Pharmaceutical Preparations for PRF Technologies and Medical/Dental Instruments for Sonoma Pharmaceuticals.